11 hrs ago
Phase II Data on OHR/AVR118 in Advanced Cancer Patients With Cachexia ...
The data were selected for podium presentation of late breaking clinical trials and were presented by principal investigator Dr. Martin Chasen, Medical Director, Palliative Care, Ottawa Hospital Cancer Centre, Canada.
Tue Dec 10, 2013
Jay W. Marks, MD, is a board-certified internist and gastroenterologist. He graduated from Yale University School of Medicine and trained in internal medicine and gastroenterology at UCLA/Cedars-Sinai Medical Center in Los Angeles.
British Journal of Cancer
Enhanced FGFR signalling predisposes pancreatic cancer to the effect...
We investigated the effect of FGFR inhibition in pancreatic cancer in complementary cancer models derived from cell lines and patient-derived primary tumour explants.
Newly Transformed Nuvilex To Enjoy Strong 2014
Following a transformational 2013 which saw the stock jump from $0.04 to $0.22 only to settle in the $0.13 range, controversial biotech stock Nuvilex, Inc. is presently undervalued and is set to make big operational strides and achieve major stock price gains in 2014.
MacReport Media RSS Feed
NewLink Genetics Initiates Phase 1 Clinical Trial of NLG919, a Novel ...
Genetics Corporation , a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced the initiation of a first in human Phase 1 clinical trial of NLG919.
Reading East MP Rob Wilson pledges support for improvements to pancreatic cancer care
A parliamentary inquiry by the All Party Parliamentary Group on Pancreatic Cancer concluded that NHS treatment for the cancer is not patient-centred, well coordinated or efficient.
Curcumin inhibits pituitary tumor cell proliferation, induces apoptosis
There is probably no traditional Asian herb that is studied more in modern western medicine laboratories than curcumin, the active ingredient of the spice turmeric.
Mon Dec 09, 2013
Up-regulation of CLDN1 in gastric cancer is correlated with reduced survival
The genetic changes in gastric adenocarcinoma are extremely complex and reliable tumor markers have not yet been identified.
Platform for Personalized Oncology: Integrative analyses reveal novel ...
Approximately 80% of Stage II colon cancer patients are cured by appropriate surgery.
Molecular Portraits of Heterogeneity Related to Cancer Stem Cells in Human Ovarian Cancer.
The aim of this study was to investigate molecular portraits of heterogeneity related to cancer stem cells in human ovarian cancer and to access the value in diagnosis and treatment.
Nuvilex Holds High Level Strategic Meetings to Solidify Company...
During the meetings, particular emphasis was placed on progress in preparing for the late-phase clinical trials of that will use the recently acquired cellulose-based live-cell encapsulation Cell-in-a-Box technology as part of the treatment for those suffering from advanced, inoperable pancreatic cancer.
Sun Dec 08, 2013
Type 2 Diabetes Might Raise Risk of Liver Cancer
SUNDAY Dec. 8, 2013, 2013 -- People with type 2 diabetes might be at somewhat higher risk of developing liver cancer, according to a large, long-term study.
Sat Dec 07, 2013
Vulvar Cancer Types
Vulvar cancer comprises 5% of the cancers of the female genital tract. Although less common, this malignancy can still contribute to significant morbidity and mortality in women.
Prayers for Ray Price and His Family Tonight in Nashville, TN
Ray Price has been battling Pancreatic Cancer since November 6, 2012. He has been in and out of the hospital several times in the last six months.
High Prevalence of BRAF Gene Mutation in Papillary Thyroid Carcinomas and Thyroid Tumor Cell Lines
The RAS-RAF-MEK-ERK-MAP kinase pathway mediates the cellular response to extracellular signals that regulate cell proliferation, differentiation, and apoptosis.
Eric Ollerenshaw column: A personal quest to try and tackle 'a dreadful killer'
Last week in Parliament I was pleased to launch the report by the All Party Parliamentary Group on Pancreatic Cancer, which I chair.
Fri Dec 06, 2013
Metabolic exploitation of the sialic acid biosynthetic pathway to...
Lack of a universal site-specific conjugation methodology for antibodies limits their potential to be developed as tumor-specific imaging agents or targeted therapeutics.
Thu Dec 05, 2013
Drugs with dual-hormone action gain attention in diabetes field
Engineered peptide drugs that simultaneously target two hormone receptors have historically attracted interest among scientists hoping to create new treatments for diabetes.
'Quiet epidemic' needs to be stopped
That was the message from Southampton surgeon Tim Underwood as he revealed his mission to tackle oesophageal cancer to one Hampshire MP.
Genes and Immunity
Genetic linkage analysis identifies Pas1 as the common locus...
Correspondence: Dr OCM Ibañez, Laboratory of Immunogenetics, Instituto Butantan, Avenida Dr Vital Brazil, 1500, São Paulo 05503-900, Brazil.